H.F. Günthard

Discipline

Economies et finances (6) Anthropologie biologique (4) Sociologie (3) Démographie (1)

Type de document

Articles (88)

Co-auteur

Date

Source

Mot-clé

cohorte (59) Human beings (52) Treatment (51) Swiss (48) Patients (46) Patients (46) thérapie (44) Therapeutics (44) virus (35) Methods (32) Immunodeficiency (32) Methods (32) Infection (31) Population (31) temps (durée) (30) risque (30) infection (30) Time (30) Risk (30) analyse (28) Population (28) Analysis (28) Transmission (28) Ci (Chinese poetry) (26) Use (26) Models (26) association (24) art (24) Art (24) Art (24)

Documents écrit par H.F. Günthard (88) | parle de H.F. Günthard (0)

Real-Life Therapeutic Concentration Monitoring of Long-Acting Cabotegravir and Rilpivirine: Preliminary Results of an Ongoing Prospective Observational Study in Switzerland.
P. Thoueille et al. (29 juil. 2022)
Developing and testing a Corona VaccinE tRiAL pLatform (COVERALL) to study Covid-19 vaccine response in immunocompromised patients.
K. Kusejko et al. (28 juil. 2022)
Increased prevalence of clonal hematopoiesis of indeterminate potential amongst people living with HIV.
A.G. Bick et al. (12 janv. 2022)
A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®.
B. Speich et al. (21 oct. 2021)
Assessing the drivers of syphilis among men who have sex with men in Switzerland reveals a key impact of screening frequency: A modelling study.
S. Balakrishna et al.
Genetic variation near CXCL12 is associated with susceptibility to HIV-related non-Hodgkin lymphoma.
C.W. Thorball et al. (1 août 2021)
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
H. Nguyen et al. (1 juin 2021)
The influence of human genetic variation on Epstein-Barr virus sequence diversity.
S. Rüeger et al. (25 févr. 2021)
Data linkage to evaluate the long-term risk of HIV infection in individuals seeking post-exposure prophylaxis.
F. Hovaguimian et al. (22 févr. 2021)
Association of Incomplete Adherence to Antiretroviral Therapy With Cardiovascular Events and Mortality in Virologically Suppressed Persons With HIV: The Swiss HIV Cohort Study.
J.R. Castillo-Mancilla et al.
The Impact of Binge Drinking on Mortality and Liver Disease in the Swiss HIV Cohort Study.
B. Surial et al. (14 janv. 2021)
Dissemination of Mycobacterium tuberculosis is associated to a SIGLEC1 null variant that limits antigen exchange via trafficking extracellular vesicles.
S. Benet et al.
Diagnosis of latent tuberculosis infection is associated with reduced HIV viral load and lower risk for opportunistic infections in people living with HIV.
K. Kusejko et al.
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.
C. Wan et al. (2 nov. 2020)
Efficacy and safety of dolutegravir plus emtricitabine versus standard ART for the maintenance of HIV-1 suppression: 48-week results of the factorial, randomized, non-inferiority SIMPL'HIV trial.
D. Sculier et al.
HCV Genetic Diversity Can Be Used to Infer Infection Recency and Time since Infection.
L.A. Carlisle et al. (31 oct. 2020)
Brief Report: Switching From TDF to TAF in HIV/HBV-Coinfected Individuals With Renal Dysfunction-A Prospective Cohort Study.
B. Surial et al. (1 oct. 2020)
Development and validation of a multiplex UHPLC-MS/MS assay with stable isotopic internal standards for the monitoring of the plasma concentrations of the antiretroviral drugs bictegravir, cabotegravir, doravirine, and rilpivirine in people living with HIV.
P. Courlet et al.
Clusters of Sexual Behavior in Human Immunodeficiency Virus-positive Men Who Have Sex With Men Reveal Highly Dissimilar Time Trends.
L. Salazar-Vizcaya et al. (16 janv. 2020)
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced Patients.
F. Olearo et al.
IL-4 polymorphism influences susceptibility to Pneumocystis jirovecii pneumonia in HIV-positive patients.
A. Wójtowicz et al.
Mortality from suicide among people living with HIV and the general Swiss population: 1988-2017.
Y. Ruffieux et al.
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.
N. Bachmann et al. (19 juil. 2019)
Inferring the age difference in HIV transmission pairs by applying phylogenetic methods on the HIV transmission network of the Swiss HIV Cohort Study.
K. Kusejko et al.
Distinct, IgG1-driven antibody response landscapes demarcate individuals with broadly HIV-1 neutralizing activity.
C. Kadelka et al. (4 juin 2018)

next